Get answers to your specific medical questions from UM Medical Center experts.
The goal of treatment is to cure the infection with antitubercular drugs. These drugs include: pyrazinamide, isoniazid (INH), rifampin, ethambutol, ethionamide, para-aminosalicylic acid (PAS), amikacin, and streptomycin. Daily oral doses are continued for 1 year or longer.
For atypical tuberculosis infections, or drug-resistant strains, other drugs may be indicated to treat the infection. A minimum of three drugs are started for treatment.
Hospitalization may be necessary to prevent the spread of the disease to others until the infectious period is over, usually 2-4 weeks after the start of therapy. Normal activity can be continued after the infectious period.
Most disseminated forms of TB respond well to treatment.
All medications used to treat TB have some toxicity. Rifampin, pyrazinamide, and isoniazid may cause a non-infectious liver inflammation. Rifampin may also cause an orange or brown coloration of tears and urine, and can stain contact lenses and undergarments. Ethambutol may reduce visual acuity or cause color blindness.
Other complications include:
Call your health care provider if known or suspected exposure to TB has occurred. All forms of TB require prompt treatment.
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |